StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.53−0.10 (-1.16%)

Close on Nov 18, 2026Market cap $253.93MP/E –Yield –

Q32 Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Q32 Bio's revenue for the twelve months ending Dec 31, 2024 was $0. For fiscal 2025 it was $53.74M. The highest annual figure on record is $53.74M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$53.74M–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023-$6.65M-307.3%
FY2022Dec 31, 2022$3.21M-90.6%
FY2021Dec 31, 2021$33.97M+1157.3%
FY2020Dec 31, 2020$2.70M+62.2%
FY2019Dec 31, 2019$1.67M-68.7%
FY2018Dec 31, 2018$5.32M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$1.86M+131.8%
Q2 FY2023Jun 30, 2023$3.21M+299.6%
Q1 FY2023Mar 31, 2023$2.95M+267.5%
Q4 FY2022Dec 31, 2022$802.00K0.0%
Q3 FY2022Sep 30, 2022$802.00K-52.2%
Q2 FY2022Jun 30, 2022$802.00K-63.3%
Q1 FY2022Mar 31, 2022$802.00K-97.3%
Q4 FY2021Dec 31, 2021$802.00K-18.2%
Q3 FY2021Sep 30, 2021$1.68M+195.8%
Q2 FY2021Jun 30, 2021$2.19M+285.7%
Q1 FY2021Mar 31, 2021$29.31M+4883.8%
Q4 FY2020Dec 31, 2020$980.00K+74.1%
Q3 FY2020Sep 30, 2020$567.00K+28.6%
Q2 FY2020Jun 30, 2020$567.00K+44.6%
Q1 FY2020Mar 31, 2020$588.00K+117.8%
Q4 FY2019Dec 31, 2019$563.00K-52.9%
Q3 FY2019Sep 30, 2019$441.00K-72.5%
Q2 FY2019Jun 30, 2019$392.00K-71.9%
Q1 FY2019Mar 31, 2019$270.00K-76.1%
Q4 FY2018Dec 31, 2018$1.20M–
Q3 FY2018Sep 30, 2018$1.60M–
Q2 FY2018Jun 30, 2018$1.40M–
Q1 FY2018Mar 31, 2018$1.13M–

More Q32 Bio figures

See a number that looks wrong?